Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor γ in non-small cell lung cancer

Cancer Research

Volumn 60, Issue 4, 2000, Pages 1129-1138

  Chang, Tsg Hui ^a   Szabo, Eva ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; GELSOLIN; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN P21; RETINOBLASTOMA PROTEIN; SURFACTANT PROTEIN A; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CELL DIFFERENTIATION; CLARA CELL; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL TYPE 2; LUNG NON SMALL CELL CANCER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIFFERENTIATION; HUMANS; LUNG NEOPLASMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0034652462     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Bloch, A. Induced cell differentiation in cancer therapy. Cancer Treat. Rep., 68: 199-205, 1984.
2. Pierce, G. B., and Speers, W. C. Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation. Cancer Res., 48: 1996-2004. 1988.
3. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell. 61: 759-767, 1990.
4. Warrell, R. P., Frankel, S. R., Miller, W. H., Scheinberg, D. A., Itri, L. M., Hittelman, W. N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., Gabrilove, S., Gordon, M. S., and Dmitrovsky, E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N. Engl. J. Med., 324: 1385-1393, 1991.
5. Mueller, E., Sarraf, P., Tontonoz, P., Evans, R. M., Martin, K. J., Zhang, M., Fletcher, C., Singer, S., and Spiegelman, B. M. Terminal differentiation of human breast cancer through PPARγ. Mol. Cell, 1: 465-470, 1998.
6. Sarraf, P., Mueller, E., Jones, D., King, F. J., DeAngelo, D, J., Partridge, J. B., Holden, S. A., Cher, L. B., Singer, S., Fletcher, C., and Spiegelman, B. M. Differentiation and reversal of malignant changes in colon cancer through PPARγ. Nat. Med., 4: 1046-1052, 1998.
7. Kitamura, S., Miyazaki, Y., Shinomura, Y., Kondo, S., Kanayama, S., and Matsuzawa, Y. Peroxisome proliferator-activated receptor γ induces growth arrest and differentiation markers of human colon cancer cells. Jpn. J. Cancer Res., 90: 75-80, 1999.
8. Spiegelman, B. M. PPAR-γ. Adipogenic regulator and thiazolidinedione receptor. Diabetes, 47: 507-514, 1998.
9. Tontonoz, P., Hu, E., and Spiegelman, B. M. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell, 79: 1147-1156, 1994.
10. Hu, E., Tontonoz, P., and Spiegelman, B. M. Transdifferentiation of myoblasts by the adipogenic transcription factors PPARγ and C/EBPα. Proc. Natl. Acad. Sci. USA, 92: 9856-9860, 1995.
11. Lambe, K. G., and Tugwood, J. D. A human peroxisome proliferator-activated receptor-γ is activated by inducers of adipogenesis, including thiazolidinedione drugs. Eur. J. Biochem., 239: 1-7, 1996.
12. 2 is a ligand for the adipocyte determination factor PPARγ. Cell, 83: 803-813, 1995.
13. Palmer, C. N. A., and Wolf, C. R. cis-Parinaric acid is a ligand for the human peroxisome proliferator activated receptor γ: development of a novel spectrophotometric assay for the discovery of PPARγ ligands. FEBS Lett., 431: 476-480, 1998.
14. Tonlonoz, P., Singer, S., Forman, B. M., Sarraf, P., Fletcher, J. A., Fletcher, C. D. M. Brun, R. P., Mueller, E., Altiok, S., Oppenheim, H., Evans, R. M., and Spiegelman, B. M. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor. Proc. Natl. Acad. Sci. USA, 94: 237-241, 1997.
15. Elstner, E., Muller, C., Koshizuka, K., Williamson, E. A., Park, D., Asou, H., Shintaku, P., Said, J. W., Heber, D., and Koeffler, H. P. Ligands for peroxisome proliferator-activated receptor γ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc. Natl Acad. Sci. USA, 95: 8806-8811, 1998.
16. Jiang. C., Ting, A. T., and Seed, B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature (Lond.), 391: 82-86, 1998.
17. Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., and Glass, C. K. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature (Lond.), 391: 79-82, 1998.
18. Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H., and Evans, R. M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell, 93: 229-240, 1998.
19. Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., and Evans, R. M. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell, 93: 241-252, 1998.
20. Marx, N., Schonbeck, U., Lazar, M. A., Libby, P., and Plutzky, J. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ. Res., 83: 1097-1103, 1998.
21. Michael, L., Lazar, M. A., and Mendelson, C. R. Peroxisome proliferator-activaled receptor γ1 expression is induced during cyclic adenosine monophosphate-stimulated differentiation of alveolar type II pneumonocytes. Endocrinology. 138: 3695-3703, 1997.
22. Jarrard, J. A., Linnoila, R. I., Lee, H. R., Steinberg, S. M., Witschi, H., and Szaho, E. MUC1 is a novel marker for the type II pneumocyte lineage during lung carcinogenesis. Cancer Res., 58: 5582-5589, 1998.
23. Szaho, E., Goheer, A., Witschi, H. P., and Linnoila, R. I. Overexpression of CC10 modifies neoplastic potential in lung cancer cells. Cell Growth Differ., 9: 475-485, 1998.
24. r 35,000 surfactant-associated protein in fetal lung. J. Biol. Chem., 262: 7908-7913, 1987.
25. Singh, G., Katyal, S. L., Brown, W. E., Phillips, S., Kennedy, A. L., Anthony, J., and Squeglia, N. Amino-acid and cDNA nucleotide sequences of human Clara cell 10 kDa protein. Biochem. Biophys. Acta, 950: 329-337, 1988.
26. Kubota, T., Koskizuka, K., Williamson, E. A., Asou, H., Said, J. W., Holden, S., Miyoshi, I., and Koeffler, H. P. Ligand for peroxisome proliferator-activated receptor y (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res., 58: 3344-3352, 1998.
27. Carney, M. E., O'Reilly, R. C., Sholevar, B., Buiakova, O. I., Lowry, L. D., Keane, W. M., Margolis, F. L., and Rothstein, J. L. Expression of the human Achaele-Scute I gene in olfactory' neuroblastoma (esthesioneuroblastoma). J. Neuro-Oncol., 26: 35-42, 1995.
28. 56, an integral membrane protein specific to human alveolar type I cells. J. Histochem. Cytochem., 47: 129-137, 1999.
29. Kwiatkowski, D. J. Predominant induction of gelsolin and actin-binding protein during myeloid differentiation. J. Biol. Chem., 263: 13857-13862, 1988.
30. Dosaka-Akita, H., Hommura, F., Fujita, H., Kinoshita, I., Nishi, M., Morikawa, T., Katoh, H., Kawakami, Y., and Kuzumaki, N. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers. Cancer Res., 58: 322-327, 1998.
31. Hurlin, P. J., Foley, K. P., Ayer, D. E., Eisenman, R. N., Hanahan, D., and Arbeit, J. M, Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. Oncogene, 11: 2487-2501, 1995.
32. Cultraro, C. M., Bino, T., and Segal, S. Function of the c-Myc antagonist Mad 1 during a molecular switch from proliferation to differentiation. Mol. Cell. Biol., 17: 2353-2359, 1997.
33. Jiang, H., Lin, J., Su, Z-z., Collart, F. R., Huberman, E., and Fisher, P. B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene, 9: 3397-3406, 1994.
34. Zhang, W., Grasso, L., McClain, C. D., Gambel, A. M., Cha, Y., Travali, S., Deisseroth, A. B., and Mercer, W. E. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/ macrophage differentiation. Cancer Res., 55: 668-674, 1995.
35. WAF1 is required for survival of differentiating neuroblastoma cells. Mol. Cell. Biol., 16: 1335-1341, 1996.
36. Missero, C., Calautti, E., Eckner, R., Chim J., Tsai, L. H., Livingston, D., and Dotto, G. P. Involvement of the cell-cycle inhibitor CipI/WAFI and the El A-associated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci. USA, 92: 5451-5455, 1995.
37. Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., and Lassar, A. B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (Washington DC), 267: 1018-1021, 1995.
38. Cip1 in muscle and other terminally differentiating cells. Science (Washington DC) , 267: 1024-1027, 1995.
39. Adamson, I. Y. R., and Bowden, D. H. The type 2 cell as progenitor of alveolar epithelial regeneration. A cytodynamic study in mice after exposure to oxygen. Lab. Investig., 30: 35-42, 1974.
40. Plopper, C. G., and Dunworth, D. L. Structure, function, cell injury, and cell renewal of bronchiolar-alveolar epithelium. In: E. M. McDowell (ed.), Lung Carcinomas, pp. 94-128. New York: Churchill Livingstone, 1987.
41. Brown, P. D., Bloxidge, R. E., Stuart, N. S. A., Gatter, K. C., and Carmichael, J. Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small cell lung carcinoma. J. Natl. Cancer Inst., 85: 574-578, 1993.
42. Betticher, D. C., Heighway, J., Hasleton, P. S., Altermatt, J. H., Ryder, W. D. J., Cerny, T., and Thatcher, N. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small cell lung cancer. Br. J. Cancer, 73: 294-300, 1996.
43. Mate, J. L., Ariza, A., Aracil, C., Lopez, D., Isamat, M., Perez-Piteira, J., and Navos-Palacios, J. J. Cyclin D1 overexpression in NSCLC: correlation with Ki-67 labelling index and poor cytoplasmic differentiation. J. Pathol., 180: 395-399, 1996.
44. INK4a expression in resected non-small cell lung tumors. Cancer Res., 56: 3415-3420, 1996.
45. Kiyokawa, H., Richon, V. M., Rifkind, R. A., and Marks, P. A. Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol. Cell. Biol., 14: 7195-7203, 1994.
46. Kranenberg, O., de Groot, R. P., Van deer Eb, A. J., and Zantema, A. Differentiation of P19 EC cells leads to differential modulation of cyclin-dependent kinase activities and to changes in the cell cycle profile. Oncogene, 10: 87-95, 1995.
47. Izurai, T., Hoshiyama, K., Enomoto, S., Sasahara, K., and Sugiyama, Y. Determination of protein binding of troglitazone stereoisomers by fluorometric titration. Biopharm. Drug Dispos., 18: 241-257, 1997.
48. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1998. CA Cancer J. Clin., 48: 6-29, 1998.
49. Tanaka, M., Mullauer, L., Ogiso, Y., Fumita, H., Moriya, S., Furuuchi, K., Harabayashi, T., Shinohara, N., Koyanagi, T., and Kizimaki, N. Gelsolin, A candidate for suppressor of human bladder cancer. Cancer Res., 55: 3228-3232, 1995.
50. Vastrik, I., Kaipainen, A., Penttila, T-L., Lymboussakis, A., Alitalo, R., Parvinen, M., and Alitalo, K. Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro. J. Cell Bio.l, 128: 1197-1208, 1995.
51. WAK1 expression induces differentiation-specific cell cycle changes in PC12 cells characteristic of nerve growth factor treatment. J. Biol. Chem., 273: 23517-23523, 1998.
52. WAF1/CIP1 induces cell differentiation and growth inhibition in a human glioma cell line. Int. J. Cancer, 75: 643-648, 1998.
53. Wesseling, J., van der Valk, S., and Hilkens, J. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/ MUC1. Mol. Biol. Cell, 7: 565-577, 1996.
54. Hilkens, J., Wesseling, J., Vos, H. L., Storm, J., Boer, B., van der Valk, S. W., and Maas, M. C. E. Involvement of the cell surface-bound mucin, episialin/MUC1, in progression of human carcinomas. Biochem. Soc. Trans., 23: 822-826, 1995.
55. Kondo, K., Kohno, N., Yokoyama, A., and Hiwada, K. Decreased MUC1 expression induces E-Cadherin-mediated cell adhesion of breast cancer cell lines. Cancer Res., 58: 2014-2019, 1998.
56. Agrawal, B., Krantz, M., Reddish, M., and Longenecker, B. Cancer-associated MUC1 mucin inhibits T-cell proliferation, which is reversible by IL-2. Nat. Med., 4: 43-49, 1998.
57. Corcoran, M. L., Hewitt, R. E., Kleiner, D. E., and Stetler-Stevenson, W. G. MMP-2: expression, activation, and inhibition. Enzyme Protein, 49: 7-19, 1996.
58. Wojtowicz-Praga, S., Torri, J., Johnson, M., Steen, V., Marshall, J., Ness, E., Dickson, R., Sale, M., Rasmussen, H. S., Chiodo, T. A., and Hawkins, M. J. Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer. J. Clin. Oncol., 16: 2150-2156, 1998.
59. Frisch, S. M., and Francis, H. Disruption of epithelial-matrix interaclions induces apoptosis. J. Cell Biol., 124: 619-626, 1994.
60. Sherr, C. J. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
61. Lonardo, F., Rusch, V., Langenfeld, J., Dmitrovsky, E., and Klimstra, D. S. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development. Cancer Res., 59: 2470-2476, 1999.
62. Martin, S. J., Bradley, J. G., and Cotter, T. G. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoplosis. Clin. Exp. Immunol., 79: 448-453, 1990.
63. Fujimura, S., Suzumiya, J., Nakamura, K., and Ono, J. Effects of troglitazone on the growth and differentiation of hematopoietic cell lines. Int. J. Oncol., 13: 1263-1267, 1998.
64. Takahashi, N., Okumura, T., Motomura, W., Fujimoto, Y., Kawabata, I., and Kohgo, Y. Activation of PPARγ inhibits cell growth and induces apoptosis in human gastric cancer cells, FEBS Lett., 455: 135-139, 1999.
65. Xin, X., Yang, S., Kowalski, J., and Gerritsen, M. E. Peroxisome proliferator-activated receptor γ ligands are potent inhibitors of angiogenesis in vitro and in vivo. J. Biol. Chem., 274: 9116-9121, 1999.
66. Demetri, G. D., Fletcher, C. D. M., Mueller, E., Sarrat, P., Naujoks, R., Campbell, N., Spiegelman, B. M., and Singer, S. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma. Proc. Natl. Acad. Sci. USA, 96: 3951-3956, 1999.
67. Huang, Y., and Waxman, S. Enhanced growth inhibition and differentiation of fluorodeoxyuridine-treated human colon carcinoma cells by phenylbulyrale. Clin. Cancer Res., 4: 2503-2509, 1998.